William Plovanic
Stock Analyst at Canaccord Genuity
(3.39)
# 993
Out of 5,120 analysts
168
Total ratings
44%
Success rate
5.17%
Average return
Main Sectors:
Stocks Rated by William Plovanic
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TNDM Tandem Diabetes Care | Maintains: Buy | $24 → $35 | $20.09 | +74.26% | 7 | Dec 17, 2025 | |
| TMDX TransMedics Group | Maintains: Buy | $147 → $148 | $133.99 | +10.46% | 9 | Dec 17, 2025 | |
| TLSI TriSalus Life Sciences | Maintains: Buy | $11 → $12 | $5.10 | +135.11% | 5 | Dec 17, 2025 | |
| EW Edwards Lifesciences | Maintains: Hold | $89 → $87 | $82.65 | +5.26% | 30 | Dec 17, 2025 | |
| CBLL CeriBell | Maintains: Buy | $29 → $30 | $20.22 | +48.37% | 5 | Dec 17, 2025 | |
| BSX Boston Scientific | Maintains: Buy | $132 → $131 | $91.87 | +42.59% | 13 | Dec 17, 2025 | |
| PODD Insulet | Maintains: Buy | $428 → $432 | $256.62 | +68.34% | 7 | Nov 24, 2025 | |
| HTFL HeartFlow | Maintains: Buy | $39 → $40 | $28.78 | +38.99% | 3 | Nov 13, 2025 | |
| AORT Artivion | Maintains: Buy | $50 → $51 | $41.23 | +23.70% | 4 | Nov 7, 2025 | |
| CVRX CVRx, Inc. | Maintains: Buy | $9 → $11 | $7.12 | +54.49% | 9 | Nov 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $193 → $212 | $155.73 | +36.13% | 13 | Oct 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $106 → $99 | $72.53 | +36.50% | 9 | Oct 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $53 → $64 | $36.82 | +73.82% | 12 | Oct 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $17 → $18 | $10.42 | +72.74% | 8 | Oct 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $8 → $7 | $1.99 | +251.76% | 4 | Aug 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $97 → $90 | $89.70 | +0.33% | 4 | Jul 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $115 → $101 | $86.22 | +17.14% | 3 | May 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $15 | $8.19 | +83.15% | 4 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $284 | $356.99 | -20.45% | 4 | Feb 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $22 → $25 | $14.49 | +72.53% | 1 | Jan 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $12 | $1.64 | +633.94% | 5 | Oct 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $86 → $70 | $81.61 | -14.23% | 4 | Aug 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $77 → $48 | $18.04 | +166.08% | 5 | Aug 3, 2023 |
Tandem Diabetes Care
Dec 17, 2025
Maintains: Buy
Price Target: $24 → $35
Current: $20.09
Upside: +74.26%
TransMedics Group
Dec 17, 2025
Maintains: Buy
Price Target: $147 → $148
Current: $133.99
Upside: +10.46%
TriSalus Life Sciences
Dec 17, 2025
Maintains: Buy
Price Target: $11 → $12
Current: $5.10
Upside: +135.11%
Edwards Lifesciences
Dec 17, 2025
Maintains: Hold
Price Target: $89 → $87
Current: $82.65
Upside: +5.26%
CeriBell
Dec 17, 2025
Maintains: Buy
Price Target: $29 → $30
Current: $20.22
Upside: +48.37%
Boston Scientific
Dec 17, 2025
Maintains: Buy
Price Target: $132 → $131
Current: $91.87
Upside: +42.59%
Insulet
Nov 24, 2025
Maintains: Buy
Price Target: $428 → $432
Current: $256.62
Upside: +68.34%
HeartFlow
Nov 13, 2025
Maintains: Buy
Price Target: $39 → $40
Current: $28.78
Upside: +38.99%
Artivion
Nov 7, 2025
Maintains: Buy
Price Target: $50 → $51
Current: $41.23
Upside: +23.70%
CVRx, Inc.
Nov 6, 2025
Maintains: Buy
Price Target: $9 → $11
Current: $7.12
Upside: +54.49%
Oct 31, 2025
Maintains: Buy
Price Target: $193 → $212
Current: $155.73
Upside: +36.13%
Oct 31, 2025
Maintains: Buy
Price Target: $106 → $99
Current: $72.53
Upside: +36.50%
Oct 30, 2025
Maintains: Buy
Price Target: $53 → $64
Current: $36.82
Upside: +73.82%
Oct 3, 2025
Maintains: Buy
Price Target: $17 → $18
Current: $10.42
Upside: +72.74%
Aug 6, 2025
Maintains: Buy
Price Target: $8 → $7
Current: $1.99
Upside: +251.76%
Jul 22, 2025
Maintains: Buy
Price Target: $97 → $90
Current: $89.70
Upside: +0.33%
May 12, 2025
Maintains: Hold
Price Target: $115 → $101
Current: $86.22
Upside: +17.14%
Nov 6, 2024
Maintains: Buy
Price Target: $12 → $15
Current: $8.19
Upside: +83.15%
Feb 23, 2024
Reiterates: Buy
Price Target: $284
Current: $356.99
Upside: -20.45%
Jan 22, 2024
Maintains: Buy
Price Target: $22 → $25
Current: $14.49
Upside: +72.53%
Oct 31, 2023
Maintains: Buy
Price Target: $20 → $12
Current: $1.64
Upside: +633.94%
Aug 28, 2023
Maintains: Hold
Price Target: $86 → $70
Current: $81.61
Upside: -14.23%
Aug 3, 2023
Downgrades: Hold
Price Target: $77 → $48
Current: $18.04
Upside: +166.08%